Toxicity Impacts of Trace-Level of F-53B in Atmospheric Particles: Implications for Low-Exposure Risk Assessment.

Mo Yang, Chu Chu, Jing-Wen Huang, Guang-Hui Dong, Nan-Xiang Jin, Marjut Roponen, Pasi I Jalava

Abstract read

In one paragraph

Article in Environmental science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mo YangInhalation Toxicology Laboratory, Department of Environmental and Biological Science, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, Kuopio FI-70211, Finland.ORCID 0000-0002-2607-779X

Chu ChuInhalation Toxicology Laboratory, Department of Environmental and Biological Science, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, Kuopio FI-70211, Finland.

Jing-Wen HuangGuangdong Provincial Engineering Technology Research Center of Environmental Pollution and Health Risk Assessment, Department of Occupational and Environmental Health, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.

Guang-Hui DongGuangdong Provincial Engineering Technology Research Center of Environmental Pollution and Health Risk Assessment, Department of Occupational and Environmental Health, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.ORCID 0000-0002-2578-3369

Nan-Xiang JinA.I.virtanen Institute for Molecular Sciences, University of Eastern Finland, Neulaniementie 2, Kuopio 70210, Finland.

Marjut RoponenInhalation Toxicology Laboratory, Department of Environmental and Biological Science, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, Kuopio FI-70211, Finland.

Pasi I JalavaInhalation Toxicology Laboratory, Department of Environmental and Biological Science, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, Kuopio FI-70211, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although previous toxicological studies on F-53B (a substitute for perfluorooctanesulfonic acid) have primarily employed relatively high exposure doses, none have simulated environmentally relevant concentrations of F-53B found in atmospheric particulate matter (PM) to assess its contribution to particle-induced toxicity. In this study, we addressed this gap by using real-world F-53B concentrations adsorbed onto PM

Indexed as

FluorocarbonsParticulate MatterAir PollutantsAtmosphereHumansOxidative StressRisk AssessmentAir PollutantsFluorocarbonsParticulate MatterF-53Bparticulate mattertoxicity evaluationtrace-level

Identifiers

PMID41084857

DOI10.1021/acs.est.5c05377

PMCPMC12574652

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.